When less is better: the safety and efficacy of reduced intensity gemcitabine in a difficult patient population with advanced non-small-cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

When less is better: the safety and efficacy of reduced intensity gemcitabine in a difficult patient population with advanced non-small-cell lung cancer

Published:2013-01-16 Issue:1 Volume:30 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Nacci A.,Calvani N.,Rizzo P.,Fedele P.,Orlando L.,Schiavone P.,Cinefra M.,Marino A.,Sponziello F.,D’Amico M.,Cinieri S.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-012-0370-1.pdf

Reference14 articles.

1. Weiss J, Stinchcombe TE. Treatment of elderly patients with stage IV non-small-cell lung cancer. Expert Rev Anticancer Ther. 2012;12(1):111–20.

2. Ganti AK, deShazo M, Weir AB, et al. 3rd Treatment of non-small cell lung cancer in the older patient. J Natl Compr Cancer Netw. 2012;10(2):230–9.

3. Quoix E, Westeel V, Zalcman G, et al. Chemotherapy in elderly patients with advanced non-small cell lung cancer. Lung Cancer. 2011;74(3):364–8.

4. Des Guetz G, Uzzan B, Nicolas P et al. Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: a meta-analysis. Crit Rev Oncol Hematol. 2012. doi: 10.1016/j.critrevonc.2012.03.007 .

5. Gridelli C, Aapro M, Ardizzoni A, et al. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. J Clin Oncol. 2005;23(13):3125–37.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP